Results 221 to 230 of about 529,483 (274)

Immune checkpoint inhibitors for the treatment of solid tumors and lymphoma in the past 26 years (2000-2025). [PDF]

J Hematol Oncol
Huang L, Zhu H, Shi Y.
europepmc   +1 more source

Efficacy and safety of fruquintinib combined with albumin‐bound paclitaxel as second‐line therapy for advanced gastric cancer following failure of PD‐1 inhibitor‐containing treatment (TACTIC GC‐01): A phase II single‐arm study

International Journal of Cancer, EarlyView.
What's New? Anti‐angiogenic drugs have shown promising efficacy as a second‐line treatment for advanced gastric cancer. However, it remains unclear how alterations in the tumor microenvironment following first‐line immunotherapy may impact tumor angiogenesis and influence subsequent therapeutic outcomes. This single‐arm study prospectively explored the
Xiaoting Ma, Kai Ou, Xiu Liu, Biyang Cao, Wenwei Yang, Jingyu Lu, Letian Zhang, Qi Wang, Lizhen Gao, Zhichao Jiang, Yongkun Sun, Lin Yang   +11 more
wiley   +1 more source

Effectiveness of Rituximab, Belimumab, and Thrombopoietin Receptor Agonists in Refractory Immune Thrombocytopenia Associated With Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis. [PDF]

Cureus
Ohta R, Ryu Y, Ichinose K.
europepmc   +1 more source

The efficacy and safety of datopotamab deruxtecan (Dato-DXd) in advanced solid tumors: a systematic review and meta-analysis. [PDF]

Eur J Med Res
Huang J, Huang T, Guo J, Hu K, Zhou H.
europepmc   +1 more source

First-line PD-1 blockades combined with TKIs for metastatic non-clear cell renal cell carcinoma: a real-world multicenter retrospective study. [PDF]

Cancer Immunol Immunother
Zhong X, Huang T, Peng Y, Jing T, Ng C, Liu X, Wei W, Zhang Z, Han H, Chen M, Huang J, Dong P.   +11 more
europepmc   +1 more source

Reply to: "NeoADAURA: Can We Afford to Overlook Objective Response Rates?" and "Is Major Pathologic Response the Best Surrogate End Point for Neoadjuvant Trials?" [PDF]

J Clin Oncol
Chaft JE, Tsuboi M, Weder W.
europepmc   +1 more source

Efficacy of Topical Beta-Blockers in Managing Epidermal Growth Factor Receptor Inhibitor-Related Paronychia and Pyogenic Granuloma-Like Lesion: A Systematic Review and Meta-Analysis. [PDF]

Cancer Med
Chan PK, Yen WT, Chen PH.
europepmc   +1 more source